Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
The National Institute for Innovation in Manufacturing Biopharmaceutic
The National Institute for Innovation in Manufacturing Biopharmaceutic
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi
The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector...
Dual-chamber packaging systems as a simplification factor in the supply chain
Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making...
Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site
The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities
The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical...
Olon releases its annual ESG report
The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in...
Upcoming event
CPhI India
26–28 November 2024 | Online Conference & Networking | Delhi, India
See all
Related Content
Research & Development
$9m goes towards advancing biopharma manufacturing in the US
NIIMBL has selected 15 new technology and talent development projects to advance the field
Regulatory
FDA partners with university on biopharmaceutical manufacturing
Delaware University and the FDA will have the ability to collaborate in a pre-competitive environment
Subscribe now